Literature DB >> 1106290

Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse.

J Mills, D Drew.   

Abstract

From 1969 to 1974, 19 cases of Serratia marcescens endocarditis were observed in the San Francisco Bay Area. Seventeen patients were intravenous drug users, and Serratia caused 14% of all addict-associated endocarditis in San Francisco. Serratia strains were nonpigmented and had typical antibiotic sensitivities, except that 9 of the isolates exhibited colonial variation, with each variant having different antibiotic sensitivities. Aortic or mitral valves were involved in 13 patients, and heart failure developed in 9 of these. Twelve patients had embolic episodes to brain, iliofemoral arteries, or lung. Five of 6 patients with tricuspid valvulitis were cured by antibiotics either with (1) or without excision of the valve. All 12 patients with aortic or mitral valvulitis treated medically died; 11 had unremitting sepsis. Aortic valve replacement and antibiotics were effective in 1. Gentamicin combined with either carbenicillin or chloramphenicol was the most effective treatment regimen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1106290     DOI: 10.7326/0003-4819-84-1-29

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  29 in total

1.  Gram-negative endocarditis.

Authors:  Milagros P Reyes; Katherine C Reyes
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

2.  Evaluation of antibiotic susceptibility testing by agar dilution and the Micro Media system (Fox Panel).

Authors:  W D Welch; M A Layman; L Chiles; R Ragsdale; E Kutscher; P M Southern
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

Review 3.  Value of the serum bactericidal test in management of patients with bacterial endocarditis.

Authors:  J W Mellors; D L Coleman; V T Andriole
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

Review 4.  Evolving epidemiology of Pseudomonas aeruginosa infections.

Authors:  A S Cross
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

5.  Protective role of complement in experimental Escherichia coli endocarditis.

Authors:  D T Durack; P B Beeson
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

6.  Association of infection caused by Pseudomonas aeruginosa serotype O11 with intravenous abuse of pentazocine mixed with tripelennamine.

Authors:  M H Levin; R A Weinstein; C Nathan; R K Selander; H Ochman; S A Kabins
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

7.  In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.

Authors:  S M Pogwizd; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

8.  Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort.

Authors:  Marco Falcone; Giusy Tiseo; Emanuele Durante-Mangoni; Veronica Ravasio; Francesco Barbaro; Maria Paola Ursi; Maria Bruna Pasticci; Matteo Bassetti; Paolo Grossi; Mario Venditti; Marco Rizzi
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

9.  Marvelous but Morbid: Infective endocarditis due to Serratia marcescens.

Authors:  Varun K Phadke; Jesse T Jacob
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2016-05

10.  Methadone: antimicrobial activity and interaction with antibiotics.

Authors:  J N Sheagren; I S Barsoum; M Y Lin
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.